NetworkNewsBreaks

ThursdayMay 18, 2017 1:43 pm

NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating on Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)

Aegis Capital has reiterated a ‘Buy’ rating and price target of $25 on shares of Concert Pharmaceuticals, Inc. (NASDAQ: CNCE). The company recently said it has received notice from the FDA that its CTP-543 phase 2a clinical trial for alopecia areata has been placed on clinical hold. The FDA is requesting a review of non-clinical toxicology studies to evaluate the planned one-year dosing. Concert said it intends to submit a response shortly, which the FDA will review within 30 days. The analyst noted the hold and said he believes the issue will be easily resolved without a long delay in…

Continue Reading

ThursdayMay 18, 2017 12:09 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 18, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ARQL 34.12% – News: Presenting at EHA Congress on June 23 in Madrid, Spain TNTY 21.88% – News: Forms joint-venture subsidiary MRMD 10.01% – News: Reports Q1 2017 revenue OPXS 4.17% – News: Secures $2.16M supplier agreement SIRI 4.02% – News: Launches new talk show with actress Anne Heche QUMU 3.47% – News: Unveils Qx video platform VSTM 3.12% – News: Presenting at EHA Congress on June 25 CASI 3.09% – News: Presenting at…

Continue Reading

ThursdayMay 18, 2017 12:05 pm

NetworkNewsBreaks – EnteroMedics, Inc. (NASDAQ: ETRM) Shares Surge on First vBloc® Neurometabolic Therapy Implant

EnteroMedics (NASDAQ: ETRM) shares are up 12% late-morning following news that the first implant of the company's vBloc® Neurometabolic Therapy was successfully completed at the McGuire Veterans Affairs Medical Center (Richmond VAMC) in Richmond, Virginia, earlier this week. The pacemaker-like device works to control sensations of hunger to enable patients to control their appetite and lose weight. "With our first implant at the Richmond VAMC, we are making vBloc accessible to an even larger portion of the men and women who have served our country selflessly and are in need of solutions to address their obesity. Through our previously announced…

Continue Reading

WednesdayMay 17, 2017 2:13 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 17, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: WNDW 6.66% – News: Successfully processes electricity-generating glass at commercial window fabricator WSTL 6.34% – News: Board authorizes new $2M stock repurchase program DRYS 4.73% – News: Takes delivery of Kamsarmax drybulk carrier ALDX 3.53% – News: Presents phase 2 clinical trial ADX-102 results at ARVO 2017 annual meeting EGLT 2.75% – News: ARYMO™ ER data published in two medical journals ISCO 2.48% – News: Posts Q1 2017 financial results CGRW 2.46% – News:…

Continue Reading

WednesdayMay 17, 2017 12:57 pm

NetworkNewsBreaks – NightFood Holdings, Inc. (NGTF) Engages Common Thread Collective as Online Commerce Partner; Shares Soar

Shares of NightFood Holdings (OTCQB: NGTF) climbed 38% after the company named Common Thread Collective (CTC) as its online commerce partner. CTC specializes in the active lifestyle consumer goods space and helps its clients establish influencer and ambassador relationships, drive e-commerce sales and build a digital community around the brand. "Their leadership team is made up of guys that have played sports at the highest levels, so you know they're competitors. But they also have a track record of taking consumer goods companies from very early stages to tens of millions in online revenue. We're confident they can do the…

Continue Reading

WednesdayMay 17, 2017 12:55 pm

NetworkNewsBreaks – Cemtrex (NASDAQ: CETX) Shares Climb on Report of Over $21M in Orders During April

Cemtrex (NASDAQ: CETX) shares surged more than 30% this morning on news that during the month of April the company received more than $21 million in new orders. Among the contracts placed during this period is a three-year agreement worth approximately $15 million for the company’s electronics manufacturing services business in Germany. The contract is the largest order placed with the company to date. “We are experiencing a build out of customer activity as our sales and marketing team ramps up their outreach. The activity we are seeing in our sales pipeline validates our expanded investments in sales and marketing…

Continue Reading

WednesdayMay 17, 2017 11:15 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) is Bridging America’s Skills Gap with Proprietary Suite of Technical Training Programs

A recent Bureau of Labor Statistics Job Openings and Labor Turnover Summary (JOLTS) shows that the number of U.S. manufacturing jobs added in March 2017 was the highest in any month since the commencement of the recession in 2008; the downside reported in the summary is that a significant skills gap is present in America, which is evidenced by massive manufacturing layoffs that are taking place concurrent with the recent increase in hiring. ProBility Media Corp. (OTCQB: PBYA) is poised to profit as it endeavors to fill the nationwide skills gap and empower America’s craftsmen and skilled workers with an…

Continue Reading

WednesdayMay 17, 2017 11:12 am

NetworkNewsBreaks – Consilium Global Research Report Projects ChineseInvestors.com, Inc. (CIIX) Will Reach $14.8M in Revenues by FY2020

A recent research report published by Consilium Global Research predicts that ChineseInvestors.com (OTCQB: CIIX) will reach revenues of $14.8 million by fiscal year 2020 and that the company will undergo a major transformation this year as it pursues a bigger stake in the cannabis market. As cited in the report, ChineseInvestors.com achieved $930,000 in revenue for FY 2016, and the company is projected to continue growing at an estimated CAGR of 100 percent through 2020, while the underlying market’s CAGR is predicted to grow at a rate of 80 percent. “Headquartered in San Gabriel, California, CIIX offers a range of…

Continue Reading

WednesdayMay 17, 2017 11:10 am

NetworkNewsBreaks – Ocera Therapeutics, Inc. (NASDAQ: OCRX) Reiterated with “Buy” Rating at Aegis Capital

Aegis Capital has reiterated a ‘Buy’ rating and price target of $3 on Ocera Therapeutics (NASDAQ: OCRX) following the company’s recent report of financial results for the quarter ended March 31, 2017. Ocera reported cash, cash equivalents and marketable securities of $25.2 million and restated prior guidance of cash on hand supporting operations into the second quarter of 2018. The company also provided an update on its clinical development programs of OCR-002 for the treatment of hepatic encephalopathy (HE). The company is expected to have an end of phase 2 meeting with the FDA in the third quarter of 2017, which…

Continue Reading

WednesdayMay 17, 2017 11:08 am

NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating on Akebia Therapeutics, Inc. (NASDAQ: AKBA)

Aegis Capital has reiterated a ‘Buy’ rating and a price target of $25 on Akebia Therapeutics (NASDAQ: AKBA) following the company’s recent report of financial results for the first quarter ended March 31, 2017. Akebia reported cash, cash equivalents and marketable securities of $251.8 million. Combined with additional upcoming payments, the company said it expects to have resources to fund the current operating plan into the first quarter of 2019. Among other highlights, the analyst noted Akebia’s upcoming milestones, including the top-line results of a phase 2 trial in Japan in the second half of 2017; the initiation of a…

Continue Reading